We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

105 hedge funds and large institutions have $68.8M invested in Sanofi Contingent Value Rights in 2019 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 9

2% more funds holding

Funds holding: 103 → 105 (+2)

7% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 15

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

6% less capital invested

Capital invested by funds: $73.1M → $68.8M (-$4.28M)

Holders
105
Holders Change
+2
Holders Change %
+1.94%
% of All Funds
2.27%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
13
Increased
16
Reduced
15
Closed
9
Calls
$15.8M
Puts
–
Net Calls
+$15.8M
Net Calls Change
+$616K

Top Buyers

Rank Fund Capital Flow
1
BHMP
Bardin Hill Management Partners
New York
+$430K
2
SCM
Stonehill Capital Management
New York
+$153K
3
Citadel Advisors
Citadel Advisors
Florida
+$97.1K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$67.2K
5
HCM
Highbridge Capital Management
New York
+$53.2K

Top Sellers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
-$558K
2
Korea Investment Corp
Korea Investment Corp
South Korea
-$23K
3
CL
CSS LLC
Illinois
-$11.3K
4
US Bancorp
US Bancorp
Minnesota
-$4.67K
5
Ameriprise
Ameriprise
Minnesota
-$3.65K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
51
BlackRock
New York
$5K – – –
DA
52
Dillon & Associates
Michigan
$5K – – –
PNC Financial Services Group
53
PNC Financial Services Group
Pennsylvania
$4K -$9 -20 -0.2%
Bank of Montreal
54
Bank of Montreal
Ontario, Canada
$3K -$70 -150 -2%
CAPTRUST Financial Advisors
55
CAPTRUST Financial Advisors
North Carolina
$3K – – –
Deutsche Bank
56
Deutsche Bank
Germany
$3K – – –
BNP Paribas Financial Markets
57
BNP Paribas Financial Markets
France
$2.46K – – –
AG
58
Advisor Group
Arizona
$2K -$345 -740 -14%
US Bancorp
59
US Bancorp
Minnesota
$1K -$4.67K -10,000 -88%
LTFS
60
Ladenburg Thalmann Financial Services
Florida
$1K -$95 -203 -8%
CT
61
Clearstead Trust
Maine
$1K – – –
WAM
62
Wealthspire Advisors (Maryland)
Maryland
$1K +$248 +532 +67%
Royal Bank of Canada
63
Royal Bank of Canada
Ontario, Canada
$1K +$294 +629 +17%
ACA
64
Atlas Capital Advisors
Wyoming
$126 – – –
RE
65
RBC Europe
United Kingdom
$59 – – –
BCWM
66
Bartlett & Co Wealth Management
Ohio
$45 – – –
KFS
67
Kelly Financial Services
Massachusetts
$23 +$23 +50 New
ECM
68
Estabrook Capital Management
New York
$6 – – –
UOC
69
UBS O'Connor
Illinois
– -$558K -1,162,096 Closed
Korea Investment Corp
70
Korea Investment Corp
South Korea
– -$23K -46,900 Closed
FNC
71
First National Corp
Massachusetts
– +$1 +2 New
CFGS
72
Concourse Financial Group Securities
Alabama
– +$5 +10 New
PCMK
73
Paragon Capital Management (Kansas)
Kansas
– +$7 +14 New
EWM
74
Edge Wealth Management
New York
– +$16 +34 New
NFH
75
NEXT Financial Holdings
Texas
– +$16 +35 New
1 2
3
4

GCVRZ Hedge Fund Activity: Q1 2019 in Review

105 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q1 2019, worth a combined $68.8M — down 5.9% from $73.1M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new GCVRZ positions and 9 closed out — a net gain of 4 holders — while 16 added to existing stakes and 15 trimmed.

The largest buyer was Bardin Hill Management Partners, opening a new position worth an estimated $430K. The largest seller was UBS O'Connor, exiting entirely with an estimated $558K sold.

  • 105 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q1 2019, up from 103 in Q4 2018.
  • Funds reported $68.8M of Sanofi Contingent Value Rights stock for Q1 2019, down 5.9% quarter-over-quarter.
  • 13 funds opened new Sanofi Contingent Value Rights positions in Q1 2019 and 9 closed out, a net change of +4 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q1 2019 was Bardin Hill Management Partners, an estimated $430K added.
  • The largest Sanofi Contingent Value Rights seller in Q1 2019 was UBS O'Connor, an estimated $558K sold.

Based on aggregated 13F filings for Q1 2019.